Welcome to our dedicated page for Jpmorgan Chase SEC filings (Ticker: JPM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The JPMorgan Chase & Co. (NYSE: JPM) SEC filings page on Stock Titan provides access to the firm’s regulatory disclosures as a leading financial services company based in the United States with operations worldwide. Through these filings, investors can review how the firm reports on its commercial banking, consumer and small business services, corporate and investment banking, financial transaction processing and asset and wealth management activities.
Current and periodic reports such as Form 8-K detail material events, earnings announcements, capital markets transactions and governance changes. Recent 8-K filings include information on quarterly financial results, investor presentations reviewing earnings, public offerings of fixed-to-floating rate notes and the resignation of a member of the Board of Directors. These documents help investors track developments affecting JPMorgan Chase’s capital structure, funding and leadership.
Filings also list the securities registered under Section 12(b) of the Securities Exchange Act. JPMorgan Chase’s common stock trades on the New York Stock Exchange under the symbol JPM. The firm has multiple series of non-cumulative preferred stock represented by depositary shares, each trading under its own symbol, and it guarantees certain notes and exchange-traded notes issued by JPMorgan Chase Financial Company LLC that are listed on the New York Stock Exchange and NYSE Arca.
On Stock Titan, these SEC filings are updated from the EDGAR system and paired with AI-powered summaries that explain key points in clear language. Investors can use this page to quickly understand the implications of earnings releases (Form 8-K items on results of operations), capital markets activity, preferred stock and note offerings, and other corporate events disclosed in JPMorgan Chase’s regulatory reports, without reading every line of the underlying documents.
JPMorgan Chase & Co. executive Troy L. Rohrbaugh, Co-CEO of the Corporate & Investment Bank, reported an open-market sale of company stock. On February 19, 2026, he sold 50,000 shares of JPM common stock at an average price of $307.1134 per share.
After this transaction, Rohrbaugh directly owned 111,279 shares of JPM common stock. The filing also notes an indirect holding of 92.3743 shares through a 401(k) plan.
JPMorgan Chase & Co. notifies the SEC of an intended sale of 432 shares of its common stock under Rule 144. The securities were acquired as awards on 01/13/2026 and are registered for sale through J.P. Morgan Securities LLC. The filing classifies the shares as equity compensation.
JPMorgan Chase & Co. (JPM) filed a Form 144 notifying a proposed sale of 50,000 shares of Common Stock with an aggregate amount of $15,355,671.70, dated 02/19/2026. The filing lists securities acquired as awards on 01/13/2019 (30,347 shares) and 01/13/2026 (19,653 shares).
JPMorgan Chase & Co. Chairman and CEO James Dimon reported indirect open-market sales totaling 69,512 shares of common stock on February 19, 2026. The shares were sold by family trusts associated with Dimon at prices in the $307.19 per-share range, and he disclaims beneficial ownership except to the extent of any pecuniary interest.
After these sales, the family trusts still held 4,209,284 shares as of the transaction date. Dimon also reported 1,667,862 shares held directly, plus additional indirect holdings through a 401(k), an LLC, and his spouse, indicating a substantial continuing stake in JPMorgan stock.
JPMorgan Chase & Co. filed a Form 144 reporting an intent to sell common stock through J.P. Morgan Securities LLC on 02/19/2026. The filing lists share lots including 15,000 shares acquired 10/13/2017 and 54,512 shares acquired 10/16/2019.
JPMorgan Chase executive Douglas B. Petno, Co-CEO of the Corporate & Investment Bank, reported an open-market sale of company stock. On February 17, 2026, he sold 3,487 shares of JPMorgan Chase common stock at $306.4035 per share. After this trade, he holds 364,828 shares directly and 70,457 shares indirectly through family trusts.
JPMorgan Chase executive Mary E. Erdoes, CEO of Asset & Wealth Management, reported an open-market sale of 5,731 shares of common stock at $306.4118 per share on February 17, 2026. After this transaction, she directly holds 613,405 JPMorgan Chase shares.
JPMorgan Chase & Co.'s Chief Information Officer Lori A. Beer reported an open-market sale of company stock. On February 17, 2026, she sold 2,047 shares of common stock at a price of $306.4031 per share. After this transaction, she directly beneficially owned 60,452 shares of JPMorgan Chase common stock.
JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum reported an open-market sale of 2,892 shares of common stock on February 17, 2026 at $306.4167 per share. Following this transaction, he directly owned 23,804 shares of JPMorgan Chase common stock.
JPMorgan Chase executive Lake Marianne reported an open-market sale of 3,907 shares of common stock at $306.4137 per share. The transaction was executed on February 17, 2026 through Grantor Retained Annuity Trusts, which hold 137,299 shares indirectly after the sale.
Separately from these GRAT holdings, she is shown with 48,017 shares held directly and 64,271 shares held indirectly through a Family Trust. Footnote disclosures explain earlier February 2026 transfers among a GRAT, a Family Trust, and the Grantor that were treated as exempt under Rule 16a-13.